Randomized, double blind placebo-controlled studies to evaluate the safety and tolerability of a novel Llama-derived anti-rotavirus VHH fragment in human volunteers (Part-I), and its therapeutic efficacy in children with rotavirus diarrhoea (Part-II)

Full metadata record
DC FieldValueLanguage
dc.contributor.authorSarker, Shafiqul A.-
dc.date.accessioned2014-06-24T08:45:00Z-
dc.date.available2014-06-24T08:45:00Z-
dc.date.issued2004-
dc.identifier.urihttp://hdl.handle.net/123456789/5126-
dc.format.extent753664 bytes-
dc.format.mimetypeapplication/msword-
dc.language.isoenen
dc.publisherDhaka: International Centre for Diarrhoeal Diseases Research, Bangladesh; 2004en
dc.relation.ispartofseriesicddrb research protocol no. 2004-009en
dc.subjectClinical protocolsen
dc.subjectRotavirusen
dc.subjectDiarrhoeal, infantileen
dc.titleRandomized, double blind placebo-controlled studies to evaluate the safety and tolerability of a novel Llama-derived anti-rotavirus VHH fragment in human volunteers (Part-I), and its therapeutic efficacy in children with rotavirus diarrhoea (Part-II)en
dc.typeOtheren
Appears in Collections:Clinical sciences research protocols

Files in This Item:
File Description SizeFormat 
ICDDRBProtocol-2004-009.doc736 kBMicrosoft WordView/Open


This item is protected by original copyright